Selegiline HC1: Selective MAO-type B inhibitor

Subthalamic deep brain stimulation and impulse control in Parkinson's disease.

European journal of neurology·2009

A comparison of Parkinson's disease symptoms and self-reported functioning and well being.

Parkinsonism & related disorders·2008

Topiramate in essential tremor: a double-blind, placebo-controlled trial.

Neurology·2006

Apolipoprotein E controls the risk and age at onset of Parkinson disease.

Neurology·2004

Advances in the treatment of Parkinson's disease.

Drugs of today (Barcelona, Spain : 1998)·2004

Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.

Neurology·2003

Quantifying Disease Progression in Patients With Charcot-Marie-Tooth Neuropathy Type 1A Using Quantitative Muscle MRI and Clinical Outcomes.

Neurology·2026

Glucose and Methionine Metabolism in Disorders of Consciousness After Brain Injury: An Exploratory Longitudinal PET Study.

Neurology·2026

Nongenetic Factors Associated With Onset and Severity of Hereditary Ataxia.

Neurology·2026

Associations Between Cerebral Amyloid Angiopathy, Cognitive Impairment, and Depressive Symptoms.

Neurology·2026

Rate of Autoimmune Diseases in the 10 Years Preceding Myasthenia Gravis Diagnosis: A Nationwide Cohort Study in South Korea.

Neurology·2026

Eligibility for Anti-Amyloid Therapies in Patients With Biomarker-Confirmed Atypical Alzheimer Disease Phenotypes.

Neurology·2026

Artificial Intelligence-enhanced Cannabidiol (CBD) Drug Delivery Systems: Integrating Machine Learning and Nanotechnology for Precision Therapeutic Optimization.

Mini reviews in medicinal chemistry·2026

Novel tetrazole annulation on benzopyridodiazepine derivatives as inhibitor of tropomyosin kinase B (TrkB): rational design, synthesis, biological evaluation, SAR, and in silico studies.

RSC advances·2026

A systematic evaluation framework for universal antibody-antigen binding affinity prediction and candidate recommendation.

iScience·2026

Dual-targeting CD73/PD-L1 bifunctional inhibitor: a promising cancer immunotherapy strategy.

Frontiers in immunology·2026

An empirical single-breakthrough curve workflow for rapid early-phase development of continuous capture chromatography for monoclonal antibodies and mAb-derived proteins.

Biotechnology progress·2026

Combined In Silico Approaches for Virtual Screening of Noncovalent Immunoproteasome Inhibitors for Multiple Myeloma Treatment.

Methods in molecular biology (Clifton, N.J.)·2026

Related Experiment Videos

Selegiline HC1: Selective MAO-type B inhibitor

Related Concept Videos

Subthalamic deep brain stimulation and impulse control in Parkinson's disease.

A comparison of Parkinson's disease symptoms and self-reported functioning and well being.

Topiramate in essential tremor: a double-blind, placebo-controlled trial.

Apolipoprotein E controls the risk and age at onset of Parkinson disease.

Advances in the treatment of Parkinson's disease.

Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.

Quantifying Disease Progression in Patients With Charcot-Marie-Tooth Neuropathy Type 1A Using Quantitative Muscle MRI and Clinical Outcomes.

Glucose and Methionine Metabolism in Disorders of Consciousness After Brain Injury: An Exploratory Longitudinal PET Study.

Nongenetic Factors Associated With Onset and Severity of Hereditary Ataxia.

Associations Between Cerebral Amyloid Angiopathy, Cognitive Impairment, and Depressive Symptoms.

Rate of Autoimmune Diseases in the 10 Years Preceding Myasthenia Gravis Diagnosis: A Nationwide Cohort Study in South Korea.

Eligibility for Anti-Amyloid Therapies in Patients With Biomarker-Confirmed Atypical Alzheimer Disease Phenotypes.

Artificial Intelligence-enhanced Cannabidiol (CBD) Drug Delivery Systems: Integrating Machine Learning and Nanotechnology for Precision Therapeutic Optimization.

Novel tetrazole annulation on benzopyridodiazepine derivatives as inhibitor of tropomyosin kinase B (TrkB): rational design, synthesis, biological evaluation, SAR, and in silico studies.

A systematic evaluation framework for universal antibody-antigen binding affinity prediction and candidate recommendation.

Dual-targeting CD73/PD-L1 bifunctional inhibitor: a promising cancer immunotherapy strategy.

An empirical single-breakthrough curve workflow for rapid early-phase development of continuous capture chromatography for monoclonal antibodies and mAb-derived proteins.

Combined In Silico Approaches for Virtual Screening of Noncovalent Immunoproteasome Inhibitors for Multiple Myeloma Treatment.

Related Experiment Videos

Selegiline HC1: Selective MAO-type B inhibitor

Related Concept Videos

Related Articles